Table 3.
CpG Site | Gene | Blood * (n = 15,907) |
ACC (n = 38) |
BA9 (n = 72) |
CN (n = 68) |
PUT (n = 68) |
VS (n = 65) |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
β | pval | β | pval | β | pval | β | pval | β | pval | β | pval | ||
cg05575921 | AHRR | −0.180 | 4.55 × 10−26 | −0.310 | 0.038 | −0.158 | 0.163 | −0.247 | 0.059 | −0.220 | 0.033 | −0.030 | 0.827 |
cg03636183 | F2RL3 | −0.095 | 1.12 × 10−20 | −0.117 | 0.118 | −0.010 | 0.834 | −0.056 | 0.198 | −0.016 | 0.619 | −0.080 | 0.116 |
cg09935388 | GFI1 | −0.083 | 3.14 × 10−17 | −0.162 | 0.345 | −0.183 | 0.132 | 0.163 | 0.206 | −0.060 | 0.595 | 0.142 | 0.369 |
cg12876356 | GFI1 | −0.057 | 1.49 × 10−15 | 0.022 | 0.838 | −0.041 | 0.516 | 0.028 | 0.640 | 0.025 | 0.705 | 0.028 | 0.730 |
cg12803068 | MYO1G | 0.063 | 9.06 × 10−23 | 0.075 | 0.556 | −0.045 | 0.598 | 0.101 | 0.163 | 0.082 | 0.292 | 0.014 | 0.810 |
cg13039251 | PDZD2 | 0.030 | 1.36 × 10−15 | 0.060 | 0.673 | −0.051 | 0.519 | 0.109 | 0.217 | 0.118 | 0.186 | −0.014 | 0.894 |
cg01940273 | - | −0.082 | 2.03 × 10−34 | −0.015 | 0.895 | −0.035 | 0.569 | −0.008 | 0.903 | 0.007 | 0.885 | −0.013 | 0.851 |
cg15693572 | - | 0.053 | 3.85 × 10−11 | −0.120 | 0.297 | 0.068 | 0.478 | 0.113 | 0.227 | −0.009 | 0.912 | −0.030 | 0.800 |
cg21566642 | - | −0.126 | 4.22 × 10−25 | −0.205 | 0.202 | −0.176 | 0.018 | 0.039 | 0.707 | −0.147 | 0.119 | 0.048 | 0.628 |
For the nine CpG sites derived from Maas, Vidaki [28], effect sizes and p-values of the association analyses with smoking in blood (* EWAS from Joehanes, Just [5]) and the five brain regions are summarized. Nominally significant results are highlighted in bold type. Β, EWAS effect size; pval, EWAS p-value; ACC, anterior cingulate cortex; BA9, Brodmann Area 9; CN, caudate nucleus; PUT, putamen; VS, ventral striatum.